Stempeutics partners with Global Consortium of cell therapy companies
Click here to read full article from source
India, April 7 -- Bengaluru based Stempeutics Research, a group company of Manipal Education and Medical Group (MEMG), announced that it has partnered with Global Consortium of cell therapy companies seeking European Commission Funding to Fight Against Corona! (FAC!).
Under this partnership, Stempeutics will export its stem cell product Stempeucel(R) (subject to regulatory approvals) for treating critically ill COVID-19 patients with lung disease. First the product will be clinically tested and upon successful outcomes, it intends to export the product on a regular basis. In this connection it is signing up an alliance with Educell Ltd, Slovenia.
Stempeucel(R) is an allogeneic, off the shelf, pooled mesenchymal stromal cells having anti...
To read the full article or to get the complete feed from this publication, please Contact Us